Navigation Links
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
Date:5/18/2008

Study Suggests that Adding Singulair to Advair Offers no Additional

Improvement in Overall Asthma Control

RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung function when treated with Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) as compared with Singulair (montelukast sodium). The results of the 660-subject study were presented today at the International Conference of the American Thoracic Society meeting in Toronto.

The study also showed patients treated with Advair plus Singulair saw no measurable improvement compared to patients treated with Advair alone in their asthma symptoms or albuterol use. In another comparison patients using Advair plus the intranasal corticosteroid, fluticasone propionate nasal spray, saw significant improvement in daytime nasal symptoms compared to patients treated with Advair plus Singulair (p<0.001).

"These findings give us a greater understanding of how to treat patients with asthma and seasonal allergies, two diseases that often are seen in tandem," said Rohit Katial, MD, National Jewish Medical Research Center. "By using the right combination of treatments, physicians can help patients gain relief from the symptoms of both diseases."

The study included people age 15 and up who had both persistent asthma and seasonal allergies. Patients received one of four different treatments: Advair Diskus 100/50 twice daily, Singulair 10 mg once daily, Advair 100/50 twice daily with Singulair 10 mg once daily or Advair 100/50 twice daily with fluticasone propionate nasal spray 200 mcg once daily. Those who received Advair alone had significant improvements in their morning peak expiratory flow, a measure of asthma control, as compared with Singulair alone (p<0.001). Secondary endpoints, including symptom-free days and rescue-treat
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
2. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
3. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
4. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
7. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
8. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
9. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Prism Glasses Expand the View for Patients with Hemianopia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2009)...l surgery patients achieved primary and secondary ...Newswire/ -- AcelRx Pharmaceuticals, Inc. today an...linical study evaluating the safety and efficacy o...ement of acute post-operative pain in patients req...mpared to placebo, patients receiving ARX-01 Sufen...
(Date:6/28/2009)...29 Sangamo BioSciences, ...research milestone has been achieved in its Resear...holly-owned member of the Roche Group, for the gen...or pharmaceutical protein production purposes usin...otein nuclease (ZFN) technology. Genentech scienti...
(Date:6/26/2009)...6, and OSAKA, Japan, June 27, 2009 ...today announced that Takeda Global Research & ...ates (U.S.) subsidiary received on June 26 (U.S. t... and Drug Administration (FDA) regarding the Compa...selective dipeptidyl peptidase IV (DPP-4) inhibito...
(Date:6/26/2009)...ted and New Genetic Mutations Acting Together-- ,... -- More pieces in the complex autism inheritance ...earch team including geneticists from The Children...nnsylvania School of Medicine and several collabo...erent genetic regions where rare copy number varia...
Breaking Medicine Technology:AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4Pot Cigarette Smoke Wreaks Havoc on Lungs 42349 1Pot Cigarette Smoke Wreaks Havoc on Lungs 42349 2National Physicians Study 3A Nearly One Third Would Choose Different Career Today 42345 1National Physicians Study 3A Nearly One Third Would Choose Different Career Today 42345 2Wristbands May Lessen Nausea After Radiation 42342 1Wristbands May Lessen Nausea After Radiation 42342 2Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 1Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 2Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 3Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 4
...t the , 2007 American Society of Clinical Oncology...Older Patients with AML and in,Refractory , ALL Pa...cular interaction of Aloxi(R),with , the 5-HT3 Rec...s of Glioblastoma Patients,Treated , with Multimod...urvival Analysis of Irofulven in Second-Line HRPC,...
...ewswire/ -- The Barbara,Ann Karmanos Cancer Instit...essor of medicine and oncology, presented the outc...creas cancer clinical,trials in North America and ...ancreatic cancer therapies at the American Society...cago, IL. , The clinical trial, A Phase III Random...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3
(Date:7/3/2009)...wire/ -- Republicans on the Senate Finance Committ...legislation that would eliminate coverage for abor...ose coverage for abortion services that their priv...f uninsured women will still lack a basic health c...quality of life. , , If these senators are allo...
(Date:7/3/2009)...( http://www.EvasVillage.org ), the Paterson, New ... Michael Jackson Film Print of "Thriller"..., NJ (PRWEB) July 3, 2009 -- Eva,s Village ( http:...nti-poverty charity, seeks serious inquiries only ..."Thriller" music video., , , , ,For inf...
(Date:7/3/2009)...nd three individuals have been recognized for lead...ompetition designed to reward workplace health and...e.org community released its 2009 Saxcies global s...yxchange.org/saxcies-video . The winners and final... lives to keeping others safe - are detailed here....
(Date:7/3/2009)...n opportunity for you to change your life - After ...ou will experience a noticeable relief from the te...esterol levels and blood pressure will return to n... will finally be freed from the health concerns th... , Miami, FL (PRWEB) July...
Breaking Medicine News(10 mins):Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4
...k tumor cells that indicates which cells are capab...the first evidence of cancer stem cells in head an...umber of cancer cells that replicate to drive tumo...cancer treatments sometimes fail because they are ...
...lan to bring down the HIV infection by a quarter b...ement a series of programmes towards AIDS awarenes...e Aboriginal and Torres Strait Islander community ... In corroboration with the general practitioners, ...
... on contract went on strike from Tuesday demanding... doctors were appointed three years ago on contrac...re now demanding that their job be regularised. R...tors held a meeting with state Chief Secretary M.K...
... has deteriorated following a series of three fail...Tuesday.// Castro is in 'very grave' condition fol...m an intestinal infection, El Pais said citing sou...employs top Spanish surgeon Jose Luis Garcia Sabri...
Other Medicine News:Health News:Stem Cell Marker Identified in Head and Neck Cancer 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
Medicine Products: